MedPath

Lumbricus rubellus extract

Generic Name
Lumbricus rubellus extract

Overview

No overview information available.

Indication

No indication information available.

Associated Conditions

No associated conditions information available.

Research Report

Published: Oct 24, 2025

A Comprehensive Pharmacological and Clinical Review of Lumbricus rubellus Extract and its Primary Bioactive Component, Lumbrokinase

Section 1: Historical Context and Biochemical Profile

The journey of Lumbricus rubellus extract from an ancient folk remedy to a subject of modern clinical investigation represents a compelling case study in ethnopharmacology. This section details its historical roots, the scientific discovery of its key bioactive components, its complex biochemical profile, and the physicochemical properties that underpin its therapeutic potential.

1.1. Traditional Use and Modern Discovery

The medicinal use of earthworms is deeply entrenched in the history of traditional Asian medicine, with documented applications spanning centuries in Chinese, Japanese, Korean, and Vietnamese cultures.[1] Referred to as Dilong (or "Earth Dragon") in Traditional Chinese Medicine, preparations derived from earthworms have been historically prescribed for a wide array of conditions, particularly those believed to involve circulatory stasis, inflammation, and disorders of the liver and spleen.[1] This long-standing empirical use for hematological and circulatory ailments provided a crucial foundation, suggesting the presence of potent, biologically active compounds that warranted scientific exploration.[5]

Continue reading the full research report

FDA Drug Approvals

Approved Product
Manufacturer
NDC Code
Route
Strength
Effective Date
No FDA approvals found for this drug.

EMA Drug Approvals

Approved Product
Authorization Holder
Status
Issued Date
No EMA approvals found for this drug.

HSA Drug Approvals

Approved Product
Manufacturer
Approval Number
Dosage Form
Strength
Approval Date
No HSA approvals found for this drug.

NMPA Drug Approvals

Approved Product
Company
Approval Number
Drug Type
Dosage Form
Approval Date
No NMPA approvals found for this drug.

PPB Drug Approvals

Approved Product
Registration No.
Company
Licence No.
Strength
Registration Date
No PPB approvals found for this drug.

TGA Drug Approvals

Approved Product
ARTG ID
Sponsor
Registration Type
Status
Registration Date
No TGA approvals found for this drug.

Health Canada Drug Approvals

Approved Product
Company
DIN
Dosage Form
Strength
Market Date
No Health Canada approvals found for this drug.

CIMA AEMPS Drug Approvals

Approved Product
Company
Registration Number
Pharmaceutical Form
Prescription Type
Status
No CIMA AEMPS (Spain) approvals found for this drug.

Philippines FDA Drug Approvals

Approved Product
Company
License Number
Dosage Form
Strength
Approval Date
No Philippines FDA approvals found for this drug.

Saudi SFDA Drug Approvals

Approved Product
Company
License Number
Dosage Form
Strength
Approval Date
No Saudi SFDA approvals found for this drug.

Malaysia NPRA Drug Approvals

Approved Product
Company
Registration Number
Dosage Form
Strength
Approval Date
No Malaysia NPRA approvals found for this drug.

UK EMC Drug Information

Medicine Name
MA Holder
MA Number
Pharmaceutical Form
Active Ingredient
Authorization Date
No UK EMC drug information found for this drug.

Help Us Improve

Your feedback helps us provide better drug information and insights.

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.